Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
67.75
-1.65 (-2.38%)
Apr 18, 2025, 2:45 PM CST
SHA:603392 Revenue
In the year 2024, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 2.25B CNY, down -59.25%. Beijing Wantai Biological Pharmacy Enterprise had revenue of 297.29M in the quarter ending December 31, 2024, a decrease of -45.14%.
Revenue
2.25B
Revenue Growth
-59.25%
P/S Ratio
37.92
Revenue / Employee
592.45K
Employees
3,843
Market Cap
85.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.25B | -3.27B | -59.25% |
Dec 31, 2023 | 5.51B | -5.67B | -50.73% |
Dec 31, 2022 | 11.19B | 5.43B | 94.51% |
Dec 31, 2021 | 5.75B | 3.40B | 144.25% |
Dec 31, 2020 | 2.35B | 1.17B | 98.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |